MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study

Medical Microinstruments, Inc. announced the completion of the first robotic-assisted procedure in the REMIND study, evaluating the Symani Surgical System for patients with moderate Alzheimer’s disease. This FDA-approved trial aims to assess the safety and feasibility of using robotic techniques to restore lymphatic drainage in the neck, potentially improving clearance of neurotoxins associated with disease progression. The initiative reflects a collaborative effort among specialists and could lead to new treatment pathways for Alzheimer’s.